Celsius (NASDAQ:CELH – Get Free Report) had its price objective upped by investment analysts at Needham & Company LLC from $35.00 to $40.00 in a report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC‘s price objective would indicate a potential upside of 33.21% from the company’s current price.
CELH has been the topic of several other research reports. Wall Street Zen raised shares of Celsius from a “sell” rating to a “hold” rating in a report on Sunday, October 4th. Stephens cut their price target on shares of Celsius from $65.00 to $50.00 and set an “overweight” rating for the company in a report on Monday, August 10th. Weiss Ratings downgraded shares of Celsius from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Stifel Nicolaus set a $36.00 price target on shares of Celsius in a research report on Friday. Finally, Sanford C. Bernstein cut shares of Celsius from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $44.00 to $26.00 in a research note on Friday, August 7th. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $41.76.
Check Out Our Latest Stock Report on Celsius
Celsius Stock Performance
Shares of NASDAQ:CELH opened at $30.03 on Friday. The business’s fifty day moving average price is $28.76 and its two-hundred day moving average price is $34.25. Celsius has a fifty-two week low of $23.56 and a fifty-two week high of $59.31. The stock has a market capitalization of $7.60 billion, a price-to-earnings ratio of 21.21, a price-to-earnings-growth ratio of 2.22 and a beta of 1.00. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.80 and a quick ratio of 1.42.
Celsius (NASDAQ:CELH – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. The firm had revenue of $847.23 million during the quarter, compared to analyst estimates of $800.63 million. Celsius had a return on equity of 36.52% and a net margin of 4.24%. The business’s revenue for the quarter was up 16.8% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.27) earnings per share. As a group, analysts predict that Celsius will post 1.42 EPS for the current fiscal year.
Insider Transactions at Celsius
In related news, Director Damon DeSantis purchased 16,000 shares of Celsius stock in a transaction that occurred on Tuesday, September 15th. The shares were acquired at an average price of $27.95 per share, for a total transaction of $447,200.00. Following the transaction, the director directly owned 2,728,187 shares in the company, valued at approximately $76,252,826.65. This represents a 0.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO John Fieldly purchased 18,000 shares of Celsius stock in a transaction that occurred on Thursday, September 10th. The shares were bought at an average price of $27.44 per share, for a total transaction of $493,920.00. Following the transaction, the chief executive officer owned 956,063 shares in the company, valued at $26,234,368.72. This represents a 1.92% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have acquired 66,000 shares of company stock worth $1,830,120. Insiders own 2.33% of the company’s stock.
Hedge Funds Weigh In On Celsius
A number of large investors have recently modified their holdings of CELH. Bank of New York Mellon Corp bought a new stake in shares of Celsius during the second quarter valued at approximately $43,040,000. Calamos Advisors LLC bought a new position in Celsius in the 3rd quarter worth approximately $16,623,000. Ranger Investment Management L.P. bought a new position in Celsius in the 2nd quarter worth approximately $13,629,000. Amundi raised its position in Celsius by 763.4% in the 2nd quarter. Amundi now owns 377,724 shares of the company’s stock worth $11,060,000 after purchasing an additional 333,974 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new position in Celsius in the 1st quarter worth approximately $9,819,000. 60.95% of the stock is currently owned by institutional investors and hedge funds.
More Celsius News
Here are the key news stories impacting Celsius this week:
- Positive Sentiment: Q3 revenue reached a record $847.2 million, up 16.8% year over year and above analysts’ $800.6 million estimate. Adjusted earnings of $0.41 per share also topped the $0.34 consensus. Celsius Q3 results
- Positive Sentiment: Alani Nu sales accelerated, supporting overall growth. Management also outlined plans to expand international sales and reorganized the business into three brand-led units, intended to sharpen execution across its portfolio. International growth and operating structure
- Neutral Sentiment: The earnings beat and growth outlook are constructive, but investors still face a wide range of views on CELH’s fair value. Fair value debate
- Negative Sentiment: Reports indicate the original CELSIUS brand is sliding while Alani Nu is becoming a larger growth driver. Continued weakness in the flagship brand could raise concerns about the sustainability and balance of portfolio growth. Alani Nu and the CELSIUS brand
- Negative Sentiment: A class-action lawsuit accuses Celsius of “healthwashing.” The allegations are not established findings, but the case adds potential legal and reputational risk. Class-action lawsuit report
About Celsius
Celsius Holdings, Inc (NASDAQ: CELH) develops, markets and distributes functional beverages designed to support active lifestyles. Its flagship CELSIUS brand offers carbonated and non-carbonated energy drinks, including products positioned around energy, fitness and wellness. The company also markets CELSIUS Essentials, CELSIUS Vibe and powdered drink mixes, with product formulations that commonly feature ingredients such as caffeine, vitamins and other functional components.
Founded in 2004, Celsius has expanded from a niche fitness beverage business into a broader energy-drink platform.
Featured Articles
- Five stocks we like better than Celsius
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.
